Modulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer

KV Woan, E Sahakian, EM Sotomayor… - Immunology and cell …, 2012 - Wiley Online Library
There is a growing body of evidence to support the use of histone deacetylase inhibitors
(HDACi) in the treatment of diverse conditions from autoimmunity to cancer. In this context …
被引用次数：80 相关文章

Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer

KV Woan, E Sahakian, EM Sotomayor… - … and Cell Biology, 2012 - search.proquest.com
There is a growing body of evidence to support the use of histone deacetylase inhibitors
(HDACi) in the treatment of diverse conditions from autoimmunity to cancer. In this context …

Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer.

KV Woan, E Sahakian, EM Sotomayor… - Immunology & Cell …, 2012 - search.ebscohost.com
There is a growing body of evidence to support the use of histone deacetylase inhibitors
(HDACi) in the treatment of diverse conditions from autoimmunity to cancer. In this context …

Modulation of antigen-presenting cells by HDAC inhibitors: Implications in autoimmunity and cancer

KV Woan, E Sahakian, EM Sotomayor… - Immunology and Cell …, 2012 - experts.umn.edu
There is a growing body of evidence to support the use of histone deacetylase inhibitors
(HDACi) in the treatment of diverse conditions from autoimmunity to cancer. In this context …

Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer.

KV Woan, E Sahakian, EM Sotomayor… - Immunology and Cell …, 2011 - europepmc.org
HDAC inhibitors are being increasingly used in the treatment of diverse conditions from
autoimmunity to cancer. In this context, HDACi have been ascribed many …
[HTML] nih.gov

[HTML][HTML] Modulation of Antigen Presenting Cells by HDAC inhibitors: implications in autoimmunity and cancer

KV Woan, E Sahakian, EM Sotomayor… - Immunology and cell …, 2012 - ncbi.nlm.nih.gov
HDAC inhibitors are being increasingly used in the treatment of diverse conditions from
autoimmunity to cancer. In this context, HDACi have been ascribed many …

Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer

KV Woan, E Sahakian… - … and cell biology, 2012 - pubmed.ncbi.nlm.nih.gov
There is a growing body of evidence to support the use of histone deacetylase inhibitors
(HDACi) in the treatment of diverse conditions from autoimmunity to cancer. In this context …

Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer.

KV Woan, E Sahakian, EM Sotomayor… - Immunology and Cell …, 2011 - europepmc.org
HDAC inhibitors are being increasingly used in the treatment of diverse conditions from
autoimmunity to cancer. In this context, HDACi have been ascribed many …